ReviewAnnals of translational medicine2025
Obesity-induced left atrial dysfunction across age groups and cardiovascular conditions: a comprehensive review of diagnostic advances and clinical implications.
Review in Annals of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [Metabolic/bariatric surgery is effective : What is the evidence regarding hard endpoints and long-term outcomes?]Chirurgie (Heidelberg, Germany) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obesity is a global health concern, affecting nearly half of the world's population and significantly increasing cardiovascular disease (CVD) risk. Among various cardiac impacts, left atrial (LA) dysfunction is a notable complication, especially given its association with atrial fibrillation (AF), heart failure with preserved ejection fraction (HFpEF), and diastolic dysfunction. This comprehensive review synthesizes findings from studies across age groups, from children to adults, evaluating obesity-induced alterations in LA structure and function. Using advanced diagnostic tools like speckle tracking echocardiography, we examine the impact of obesity on LA function, the potential reversibility of LA dysfunction, and implications for CVD progression. Studies show that elevated body mass index (BMI) correlates with LA enlargement, increased stiffness, and impaired reservoir and conduit strain, with specific changes observed across different cardiovascular conditions. In children, obesity-related insulin resistance is associated with increased LA stiffness, marking early indicators of metabolic and cardiac dysfunction. In adults, higher BMI independently reduces LA strain, compromising function and raising the likelihood of AF recurrence post-cardioversion or percutaneous interventions. Additionally, clinical manifestations such as exercise intolerance in obese HFpEF patients highlight LA stiffness as a predictor of poorer quality of life and reduced physical capacity. Importantly, weight loss interventions, including bariatric surgery, show promise in reversing LA dysfunction, suggesting a potential for reducing obesity-related cardiac risks. Our review underscores the value of incorporating LA strain metrics in routine cardiac assessments to identify subclinical changes early and guide preventive strategies in obese patients. Further research into therapeutic approaches targeting LA function is essential for reducing HFpEF incidence and improving cardiovascular outcomes in obesity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.